Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and core pathway aberrations. [electronic resource]
Producer: 20091103Description: 1250-4 p. digitalISSN:- 2542-5641
- Adolescent
- Adult
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents, Phytogenic -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols
- Bevacizumab
- Camptothecin -- analogs & derivatives
- Disease-Free Survival
- Female
- Glioma -- drug therapy
- Humans
- Immunohistochemistry
- Irinotecan
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.